2 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Metcela Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Safety Study Following to JRM-001 Treatment in Pediatric Patients With Congenital Heart Disease Single Ventricle, Hypoplastic Left Heart Syndrome (HLHS) | Recruiting | Metcela Inc. | 40 | 2026-09-01 | 2026-10-20 | |
| Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial) Autologous cardiac stem cells (JRM-001) - Hypoplastic Left Heart Syndrome, Single Ventricle | Phase 3 | Recruiting | Metcela Inc. | 40 | 2016-06-01 | 2026-10-19 |
Heart Defects, Congenital (2) · Hypoplastic Left Heart Syndrome (2) · Univentricular Heart (2)
Japan (2)